Who are we and what are we doing? We are a group of enthusiastic scientists that gather together once a week to discuss fresh preprints in the field of #immunology. 🦠🧬
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
Tomas Pachano and He Leng’s preprint “Systematic Discovery of Pathogen Effector Functions across Human Pathogens and Pathways”, from the labs coordinated by @alex-stark.bsky.social and @miketilapia.bsky.social
www.biorxiv.org/content/10.1...
Tomas Pachano and He Leng’s preprint “Systematic Discovery of Pathogen Effector Functions across Human Pathogens and Pathways”, from the labs coordinated by @alex-stark.bsky.social and @miketilapia.bsky.social
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.embopress.org/doi/full/10....
(1/9)
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
Mt.Sinai will present a #preprint from @maxkonigmd.bsky.social about targeting autoreactive B cells in systemic lupus erythematosus using anti-9G4 idiotope synthetic immune receptor T cells.
biorxiv.org/content/10.1...
Mt.Sinai will present a #preprint from @maxkonigmd.bsky.social about targeting autoreactive B cells in systemic lupus erythematosus using anti-9G4 idiotope synthetic immune receptor T cells.
biorxiv.org/content/10.1...
will present a #preprint by Dr.Zhejie Li from @Zhu_Lab
titled “Somatic TYK2 activating mutations in tumor-infiltrating T cells promote anti-cancer immunity."
www.biorxiv.org/content/10.1...
will present a #preprint by Dr.Zhejie Li from @Zhu_Lab
titled “Somatic TYK2 activating mutations in tumor-infiltrating T cells promote anti-cancer immunity."
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
@cemm.oeaw.ac.at will present a #preprint by
@retickerflynn.bsky.social on how Type I interferon signaling drives divergent metastatic phenotypes and immunotherapy responses 🧬🔬
www.biorxiv.org/content/10.1...
@cemm.oeaw.ac.at will present a #preprint by
@retickerflynn.bsky.social on how Type I interferon signaling drives divergent metastatic phenotypes and immunotherapy responses 🧬🔬
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...